Jeffrey T. Walsh, Chief Financial at bluebird bio, Inc. (BLUE), sold 16,500 shares at $148.75 ($2.5M) on 2017-11-10, disclosed to the SEC on 2017-11-14.
Open-market sale of $2.5M BLUE by Chief Financial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.75 | 2,100 | $312K | 12.7% |
| 2 | $149.74 | 6,600 | $988K | 40.0% |
| 3 | $149.74 | 6,600 | $988K | 40.0% |
| 4 | $150.18 | 1,200 | $180K | 7.3% |
| Total | $149.65 avg | 16,500 | $2.5M | 100% |
| Filing → |
| BLUE | SELL | 2019-06-12 | $176K | — | Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |